David Protein has raised $335M across 1 funding round, plus 2 undated rounds. The latest round valued David Protein at $725M post-money, with Greenoaks on the lead line.
David announced a $75 million Series A round in May 2025 at a reported $725 million valuation, backed by Greenoaks Capital Partners, HG Ventures and Valor Equity Partners. Its parent company, Medici Brands, later raised $250 million at a $2.25 billion valuation.
1 funding round, the latest highlighted.
David Protein was founded in 2023, United States.
No date is disclosed for this round.
Valor Equity Partners. $75M raised, led by Greenoaks.
No filing has been made.
1 dated round, newest first.
GreenoaksLEADPPeter RahalLEADGGreenoaks Capital PartnersHHG VenturesNo. David Protein is a private company; its shares do not trade on a public exchange.
The last valuation is $725M.
Lead investors for each round are in the funding timeline.
The routes section explains what is realistically available for a company at this stage.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
